Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page
- Check7 days agoChange DetectedThe study record now shows 'No longer looking for participants', indicating enrollment for the trial is closed. The page revision tag was updated from v3.5.5 to v3.6.0, reflecting an updated version of the record.SummaryDifference0.4%

- Check14 days agoChange DetectedA new revision entry, v3.5.5, has been added to the Record History, replacing the previous v3.5.4. This indicates an update to the page's metadata or release notes on ClinicalTrials.gov.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record now shows 'Active, not recruiting' instead of 'Recruiting' and adds new sections for Study Status, Recruitment Status, and Contacts/Locations. The page also includes a new last update date (2026-05-11) and revision (v3.5.4).SummaryDifference0.9%

- Check57 days agoChange DetectedThe page’s interface revision/version label was updated from v3.5.2 to v3.5.3, indicating an internal site release without changing the study history details shown.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.5.2 was added to the history; Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.